Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis (PrEP) Services for Cisgender Women (CGW) (PrEP-CGW)
Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis (PrEP) Services for Cisgender Women (CGW) (PrEP-CGW)
批准号:
10686097
负责人:
Rachel K Scott
金额:
$27.12万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-01 至 2024-08-31
关键词:
AIDS preventionAcquired Immunodeficiency SyndromeAddressAdherenceAdoptionAffectAgeAwardBarrier ContraceptionBehavior TherapyBlack raceCollectionCountryDistrict of ColumbiaDwarfismEducationEpidemicEvidence based interventionFDA approvedFamily PlanningFumaratesFundingFutureGenderGrantHIVHIV diagnosisHeterosexualsHigh Risk WomanInterventionLiteratureLocationMale CondomsMedicalModelingMulti-Institutional Clinical TrialMulticenter TrialsNational Institute of Mental HealthOralOutcome MeasurePatient-Centered CarePatientsPopulationPractical Robust Implementation and Sustainability ModelPreparationPrevalenceProviderPublic HealthReduce health disparitiesReportingResearchResearch PriorityRiskServicesSeveritiesSocial BehaviorTanzaniaTenofovirTestingTrainingUnited StatesUnited States Food and Drug AdministrationWashingtonWomanacceptability and feasibilitycis-femalecostdesignemtricitabineevidence basefallsfeasibility testingimplicit biasimprovedmulti-site trialpeerpeer supportpre-exposure prophylaxispreventpreventive interventionreproductivesocial stigmasocial structuretherapy developmenttransmission processuptakewomen of color
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Cisgender Women (CGW) account for nearly 20% of new HIV diagnoses in the United States (US) and both
research and public health efforts in HIV prevention in this population have fallen short. Most CGW acquire
HIV via heterosexual transmission, and Black CGW are disproportionately affected. Washington, D.C. (DC) is
an epicenter of the HIV epidemic in the Southern US; HIV prevalence among CGW is seven-fold higher than
the national average, and ten-fold higher among Black CGW. Given the severity and pervasiveness of the
epidemic, DC is the model location to efficiently develop and pilot a HIV prevention intervention for CGW to be
tested across the Southern US.
HIV is highly preventable through consistent use of barrier contraception and HIV pre-exposure
prophylaxis (PrEP), however there are significant socio-structural barriers to PrEP use among CGW,
including medical mistrust, cost, stigma, and lack of access. Our preliminary research in reproductive-age
CGW at high risk for HIV echoed the critical importance of medical provider and peer support in
engagement and retention in the PrEP cascade reported in the literature. There is mounting evidence to
support the importance of socio-structural interventions to address identified barriers to successful PrEP
delivery and utilization. There are currently no evidenced-based interventions to improve PrEP initiation,
adherence, and persistence among CGW in the US.
This planning proposal builds upon the successful multi-pronged approach of Project Shikamana, a socio-
structural intervention to prevent HIV among CGW in Tanzania (a NIMH R01 award, recognized by CDC
as an evidence-based intervention (EBI) led by Dr. Kerrigan (co-I) and upon the PI’s formative research with
reproductive-age CGW at high-risk for HIV in DC. In this proposal, we plan to adapt and tailor the Project
Shikamana approach to address the culturally-specific, socio-structural barriers to HIV prevention. Our
specific aims are: 1) Intervention Development: We will adapt the existing multi-pronged Project Shikamana
Intervention for use with Southern US reproductive-age Black CGW. This intervention will integrate A) provider
training to mitigate implicit biases and positively reframe HIV prevention as part of patient-centered care, and
B) peer navigation to address socio-structural barriers to PrEP initiation, adherence, and persistence.
2) Feasibility & Acceptability Testing: We will evaluate the feasibility and acceptability of this HIV prevention
intervention. Additionally, we will evaluate the feasibility of using a regression discontinuity design and the
collection of associated outcome measures to inform a future trial. We will utilize the PRISM framework to
assess patient and organizational perspectives, reach, adoption, and intervention acceptability and feasibility in
preparation for our planned, multi-site trial to increase engagement and retention in the PrEP cascade.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Population Pharmacokinetic Modeling and Clinical Trial Simulation to optimize HIV Prevention in Pregnancy and Postpartum
-
批准号:10810993
-
项目类别:
-
资助金额:$22.4万
-
财政年份:2021
-
负责人:Rachel K Scott
-
依托单位:
Socio-Structural Intervention to Improve Pre-Exposure Prophylaxis (PrEP) Services for Cisgender Women (CGW) (PrEP-CGW)
-
批准号:10327920
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2021
-
负责人:Rachel K Scott
-
依托单位:
Placental Microvasculature in Pregnancies Complicated by HIV
-
批准号:9925912
-
项目类别:
-
资助金额:$20.96万
-
财政年份:2020
-
负责人:Rachel K Scott
-
依托单位:
Placental Microvasculature in Pregnancies Complicated by HIV
-
批准号:10227665
-
项目类别:
-
资助金额:$23.51万
-
财政年份:2020
-
负责人:Rachel K Scott
-
依托单位:
Behavioral Health Determinants of Adherence in Women Living with HIV
-
批准号:9921487
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2018
-
负责人:Rachel K Scott
-
依托单位:
海外基金